Hudson Bay Capital Management’s Inozyme Pharma INZY Stock Holding History

Hudson Bay Capital Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,996	Closed	-$60K	–	1449
2025 Q2	$60K	Buy	+14,996	New	+$37.1K	﹤0.01%	1251

Hudson Bay Capital Management's INZY Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 14,996 shares — an estimated $60K sold.

Hudson Bay Capital Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $60K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Hudson Bay Capital Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Hudson Bay Capital Management sold 14,996 Inozyme Pharma shares in Q3 2025, an estimated $60K.
Hudson Bay Capital Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Hudson Bay Capital Management's Inozyme Pharma position peaked at $60K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.